Hepaglide 1.7 mg Injection

Hepaglide 1.7 mg Injection is used for weight management in individuals with obesity and chronic weight issues. It is also used for Type 2 diabetes and cardiovascular events in certain patients with Type 2 patients. It is administered once weekly on the same day subcutaneously. 

Key Features

How does Hepaglide 1. 7 mg injection work?

Hepaglide 1.7 mg injection consists of Semaglutide. Semaglutide is a GLP-1 receptor agonist. It mimics a natural hormone in the body called GLP-1 (Glucagon like peptide 1), which is released after eating to help regulate appetite and blood sugar levels. It also slows down digestion so the food stays in the body for a little longer. It decreases appetite and food intake. 

Directions for use

Here are the general guidelines for proper use:

• Inject it once a week on the same day each week according to your  convenient time. 
• Do not self-administer unless trained by a healthcare professional. 
• Do not use more than prescribed. 

Dosage

Use it as and when directed by the healthcare provider. In case you miss a dose it should be administered as soon as possible within 5 days. If it is more than 5 days, skip the missed dose and resume with the normal dosing. 

Uses

Hepaglide 1.7 mg can be used for:

• Weight management
• Liver health
• Cardiovascular risk reduction
• Type 2 diabetes

Side effects

Some of the severe side effects seen are:

• Pancreatitis
• Gallbladder problems
• Severe dehydration
• Severe allergic reactions
• Hypoglycemia
• Vision changes

Common side effects are:

• Gastrointestinal issues:Nausea, vomiting, diarrhea, constipation, etc. 
• Reduced appetite
• Systemic reactions: Fatigue, headache and dizziness
• Digestive discomfort
• Redness, pain and swelling at the site of injection
• Abdominal discomfort: Bloating, gas, heartburn

Interactions

Drug-drug interactions

• Diabetes medications: Combining Hepaglide with insulin or sulfonylureas severely increases the risk of hypoglycemia.
• Oral medications: Hepaglide can delay the absorption of other oral medications such as oral contraceptives or antibiotics which makes them less effective immediately. 
• Weight loss medications: Combining it with other GLP-1 agonists like liraglutide or tirzepatide is not recommended and increases the risk of severe gastrointestinal side effects. 
• Herbal supplements: Gymnema, bitter melon or fenugreek if taken with Semaglutide can cause blood sugar to drop too drastically

Drug-disease interactions

You should avoid or use Hepaglide with extreme caution if you have personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). 

Precautions & Warnings

• Do not use the product if you are allergic to Semaglutide or any other ingredient of the product.
• This medication is not recommended if pregnant or while breast feeding. 
• Use with caution if you have severe stomach problems like gastroparesis.
• Do not share the pens between users even if the needle is changed.
• If you are planning for pregnancy, stop using the product at least 2 months before conceiving. 
• Avoid excessive alcohol use while using the medicine as it can worsen stomach related side effects. 
• Drink lots of water to prevent dehydration. 
• Not recommended for those with serious gastrointestinal issues like gastroparesis.
• Limit alcohol intake as it can increase gastrointestinal side effects. 
• Keep unopened pens refrigerated and away from light. 

Conclusion

Hepaglide 1.7 mg Injection contains semaglutide, a medication aimed at aiding weight loss and managing blood sugar levels in adults with type 2 diabetes. For best results, it should be combined with a restricted calorie diet and regular exercise. Hepaglide should always be utilized under the supervision of a healthcare provider. 

FAQs